Loading Calculator...
Please wait a moment
Please wait a moment
Calculate HOMA-IR, HOMA-β, and QUICKI to assess insulin resistance and beta cell function
Insulin sensitivity refers to how effectively your cells respond to insulin. When you're insulin sensitive, your cells readily take up glucose from the bloodstream in response to insulin. Insulin resistance is the opposite - cells don't respond well to insulin, requiring the pancreas to produce more insulin to achieve the same effect.
HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is a widely used method to estimate insulin resistance from fasting glucose and insulin levels. It correlates well with the gold-standard euglycemic-hyperinsulinemic clamp technique but is much more practical for clinical and research use. Higher HOMA-IR values indicate greater insulin resistance.
Insulin resistance is a key feature of metabolic syndrome and a major risk factor for type 2 diabetes, cardiovascular disease, non-alcoholic fatty liver disease, and polycystic ovary syndrome (PCOS). Early detection through screening tools like HOMA-IR allows for intervention before progression to diabetes.
HOMA-β estimates pancreatic beta cell function - the ability of the pancreas to secrete insulin. Normal beta cell function adapts insulin secretion to match insulin sensitivity. In early insulin resistance, beta cells compensate by producing more insulin (high HOMA-β), maintaining normal glucose levels.
Over time, if insulin resistance persists, beta cells may become exhausted and unable to maintain adequate insulin production. This beta cell failure, combined with insulin resistance, leads to progression from normal glucose tolerance to prediabetes and eventually type 2 diabetes. HOMA-β <50% suggests reduced beta cell reserve.
The combination of HOMA-IR and HOMA-β provides insight into the balance between insulin resistance and compensatory insulin secretion. High HOMA-IR with high HOMA-β suggests compensated insulin resistance, while high HOMA-IR with low HOMA-β indicates decompensation and high diabetes risk.
Weight loss is one of the most effective ways to improve insulin sensitivity. Even modest weight loss (5-10% of body weight) can significantly reduce insulin resistance. Exercise, particularly a combination of aerobic and resistance training, improves insulin sensitivity independent of weight loss by increasing glucose uptake in muscles.
Reduce refined carbohydrates and added sugars, which cause rapid glucose and insulin spikes. Focus on high-fiber foods, whole grains, legumes, vegetables, and lean proteins. The Mediterranean diet pattern has strong evidence for improving insulin sensitivity. Consider reducing overall carbohydrate intake, particularly if significantly insulin resistant.
For individuals with prediabetes and significant insulin resistance who don't achieve sufficient improvement with lifestyle changes, metformin may be appropriate. Metformin improves insulin sensitivity and reduces diabetes risk by about 30% in high-risk individuals. Other medications targeting insulin resistance include GLP-1 agonists and SGLT2 inhibitors.
HOMA-IR and related indices are useful screening and research tools but have limitations. They're most accurate in non-diabetic individuals with fasting glucose <140 mg/dL, as the formulas assume steady-state fasting conditions. In diabetes with significantly elevated glucose, HOMA calculations become less reliable.
These calculations provide a snapshot assessment but don't capture dynamic insulin secretion or postprandial (after-meal) insulin resistance. Oral glucose tolerance testing (OGTT) with insulin measurements provides additional information about glucose and insulin responses to a standardized glucose load.
Reference ranges for HOMA-IR vary by population, age, BMI, and ethnicity. Some populations have different cut-offs for insulin resistance. Clinical interpretation should consider individual factors and trends over time. Serial measurements can track response to interventions more reliably than single measurements.
Both assess insulin sensitivity from fasting glucose and insulin, but HOMA-IR estimates insulin resistance (higher is worse) while QUICKI estimates insulin sensitivity (higher is better). QUICKI uses logarithmic transformation and is inversely related to HOMA-IR. Both correlate well with gold-standard clamp studies, with HOMA-IR being more commonly used clinically.
HOMA calculations assume steady-state conditions with stable glucose and insulin levels. Eating causes glucose and insulin to rise dramatically, invalidating the formulas. An 8-12 hour fast ensures baseline metabolic state. Even small amounts of food or caloric beverages can affect results. Water, black coffee, and tea without additives are acceptable.
Yes, absolutely. In early insulin resistance, the pancreas compensates by producing more insulin (hyperinsulinemia) to maintain normal glucose levels. Fasting insulin may be elevated even when glucose is normal. This compensated state can persist for years before beta cell exhaustion leads to rising glucose and progression to prediabetes/diabetes. This is why measuring both glucose and insulin is valuable.
HOMA-IR ≥2.9 suggests significant insulin resistance and warrants medical evaluation. However, even values in the 2.0-2.9 range indicate early insulin resistance and may benefit from lifestyle intervention and monitoring. Discuss any concerning results with your healthcare provider, especially if you have other risk factors (obesity, family history of diabetes, sedentary lifestyle, PCOS).
Initially, beta cells compensate for insulin resistance by producing more insulin, maintaining normal glucose. Over time, chronic insulin resistance and hyperinsulinemia stress beta cells, leading to dysfunction and reduced insulin secretion. When insulin production can no longer overcome resistance, glucose rises, progressing from normal to prediabetes (impaired fasting glucose/glucose tolerance) to diabetes. The process typically takes years.
Yes, several medications affect insulin sensitivity or insulin/glucose levels. Metformin improves insulin sensitivity. Steroids (prednisone) worsen insulin resistance. Beta-blockers can affect insulin secretion. Statins may slightly worsen insulin resistance. Thiazide diuretics can raise glucose. Inform your healthcare provider of all medications when interpreting results. Some may need to be temporarily held before testing.
For individuals with insulin resistance implementing lifestyle changes, reassessment every 3-6 months is reasonable to monitor progress. For those with normal results but risk factors, annual screening may be appropriate. More frequent monitoring may be warranted if on medications affecting insulin sensitivity or during weight loss interventions. Your healthcare provider can recommend an appropriate schedule.
Yes, in most cases insulin resistance is reversible with lifestyle interventions, particularly weight loss and exercise. The degree of reversibility depends on duration, severity, and individual factors. Early insulin resistance is highly responsive to lifestyle changes. Long-standing severe insulin resistance may be more difficult to fully reverse but still improves significantly with intervention. Genetic factors also play a role in individual variability.